1. Research & Biopharmacy, Institut de Recherches Internationales Servier, Suresnes, France
2. Pathology Sciences, Drug Safety and Metabolism, AstraZeneca R&D, Cambridge, UK
3. Preclinical Safety, AbbVie, North Chicago, USA
4. Non Clinical Development, Chemin du Foriest, UCB BioPharma SPRL, Braine L’Alleud, Belgium
5. Drug ADME Research, H. Lundbeck A/S, 9 Ottiliavej, Valby, Denmark
6. Non-Clinical Development, Merck KGaA, Darmstadt, Germany
7. In Vitro Biology, Orion Pharma, Espoo, Finland
8. Investigative Toxicology, Preclinical Safety, Sanofi R&D, Paris, France
9. Preclinical Development & Safety, Janssen (Pharmaceutical Companies of Johnson & Johnson) Turnhoutseweg 30, Beerse, Belgium
10. Innovative Medicines and Early Clinical Development, Drug Safety and Metabolism, Discovery Safety, AstraZeneca R&D, Mölndal, Sweden
11. Pharmacokinetics Dynamics & Metabolism, Janssen (Pharmaceutical Companies of Johnson & Johnson) Turnhoutseweg 30, Beerse, Belgium
12. Dept of Toxicology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA
13. Investigative Safety & Drug Metabolism, GlaxoSmithKline, David Jack Centre for Research and Development, Ware, Herts, Hertfordshire, UK
14. Institute of Translational Medicine, University of Liverpool, Liverpool, UK